Lifecare AS (LIFE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lifecare AS (LIFE) has a cash flow conversion efficiency ratio of 3.325x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-22.15 Million ≈ $-2.33 Million USD) by net assets (Nkr-6.66 Million ≈ $-700.93K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review how financially flexible is Lifecare AS to assess the company's free cash flow relative to its total liabilities.
Lifecare AS - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Lifecare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Lifecare AS (LIFE) market capitalisation for the company's overall valuation and market capitalisation.
Lifecare AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifecare AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GIGLIO.COM S.P.A. O.N.
F:5JR0
|
N/A |
|
Ecoslops SA
PA:ALESA
|
0.259x |
|
Meihua International Medical Technologies Co. Ltd.
NASDAQ:MHUAF
|
0.055x |
|
Polar Power Inc
NASDAQ:POLA
|
-0.917x |
|
Palred Technologies Limited
NSE:PALREDTEC
|
0.041x |
|
Rossi Residencial S.A
SA:RSID3
|
-0.033x |
|
Nala Digital Commerce Ltd
TA:SEFA
|
0.343x |
|
Pantera Lithium Ltd
AU:PFE
|
-0.028x |
Annual Cash Flow Conversion Efficiency for Lifecare AS (2017–2024)
The table below shows the annual cash flow conversion efficiency of Lifecare AS from 2017 to 2024. View LIFE stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr73.98 Million ≈ $7.78 Million |
Nkr-65.54 Million ≈ $-6.90 Million |
-0.886x | -63.52% |
| 2023-12-31 | Nkr66.45 Million ≈ $6.99 Million |
Nkr-36.00 Million ≈ $-3.79 Million |
-0.542x | -67.72% |
| 2022-12-31 | Nkr55.25 Million ≈ $5.81 Million |
Nkr-17.85 Million ≈ $-1.88 Million |
-0.323x | +43.13% |
| 2021-12-31 | Nkr24.25 Million ≈ $2.55 Million |
Nkr-13.77 Million ≈ $-1.45 Million |
-0.568x | -170.03% |
| 2020-12-31 | Nkr13.33 Million ≈ $1.40 Million |
Nkr-2.80 Million ≈ $-294.99K |
-0.210x | +50.64% |
| 2019-12-31 | Nkr15.73 Million ≈ $1.66 Million |
Nkr-6.70 Million ≈ $-705.49K |
-0.426x | -41.36% |
| 2018-12-31 | Nkr22.24 Million ≈ $2.34 Million |
Nkr-6.70 Million ≈ $-705.49K |
-0.301x | -110.57% |
| 2017-12-31 | Nkr-2.35 Million ≈ $-247.41K |
Nkr-6.70 Million ≈ $-705.49K |
2.852x | -- |
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures … Read more